Literature DB >> 19060899

Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptor-induced proliferation.

Srividya Sriskantharajah1, Monica P Belich, Stamatia Papoutsopoulou, Julia Janzen, Victor Tybulewicz, Benedict Seddon, Steven C Ley.   

Abstract

To investigate the importance of proteolysis of NF-kappaB1 p105 induced by the kinase IKK in activation of the transcription factor NF-kappaB, we generated 'Nfkb1(SSAA/SSAA)' mice, in which the IKK-target serine residues of p105 were substituted with alanine. Nfkb1(SSAA/SSAA) mice had far fewer CD4+ regulatory and memory T cells because of cell-autonomous defects. These T cell subtypes require activation of NF-kappaB by the T cell antigen receptor for their generation, and the Nfkb1(SSAA) mutation resulted in less activation of NF-kappaB in CD4+ T cells and proliferation of CD4+ T cells after stimulation of the T cell antigen receptor. The Nfkb1(SSAA) mutation also blocked the ability of CD4+ T cells to provide help to wild-type B cells during a primary antibody response. IKK-induced p105 proteolysis is therefore essential for optimal T cell antigen receptor-induced activation of NF-kappaB and mature CD4+ T cell function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060899     DOI: 10.1038/ni.1685

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  44 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

Authors:  Xuguang Tai; Michelle Cowan; Lionel Feigenbaum; Alfred Singer
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

3.  A fourth IkappaB protein within the NF-kappaB signaling module.

Authors:  Soumen Basak; Hana Kim; Jeffrey D Kearns; Vinay Tergaonkar; Ellen O'Dea; Shannon L Werner; Chris A Benedict; Carl F Ware; Gourisankar Ghosh; Inder M Verma; Alexander Hoffmann
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

Review 4.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

5.  Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.

Authors:  A Orian; A L Schwartz; A Israël; S Whiteside; C Kahana; A Ciechanover
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

Authors:  Matthew A Burchill; Jianying Yang; Christine Vogtenhuber; Bruce R Blazar; Michael A Farrar
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

7.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

Authors:  Q Li; D Van Antwerp; F Mercurio; K F Lee; I M Verma
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

8.  Mature T cells depend on signaling through the IKK complex.

Authors:  Marc Schmidt-Supprian; Gilles Courtois; Jane Tian; Anthony J Coyle; Alain Israël; Klaus Rajewsky; Manolis Pasparakis
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

9.  The precursor of NF-kappa B p50 has I kappa B-like functions.

Authors:  N R Rice; M L MacKichan; A Israël
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

10.  Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules.

Authors:  J Kirberg; A Berns; H von Boehmer
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

View more
  43 in total

1.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

Review 2.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 3.  The persistence of T cell memory.

Authors:  Mark A Daniels; Emma Teixeiro
Journal:  Cell Mol Life Sci       Date:  2010-04-04       Impact factor: 9.261

Review 4.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

5.  PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.

Authors:  Lindsay M Webb; Stephanie A Amici; Kyle A Jablonski; Himanshu Savardekar; Amanda R Panfil; Linsen Li; Wei Zhou; Kevin Peine; Vrajesh Karkhanis; Eric M Bachelder; Kristy M Ainslie; Patrick L Green; Chenglong Li; Robert A Baiocchi; Mireia Guerau-de-Arellano
Journal:  J Immunol       Date:  2017-01-13       Impact factor: 5.422

6.  Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death.

Authors:  Bridget Larkin; Vladimir Ilyukha; Maxim Sorokin; Anton Buzdin; Edouard Vannier; Alexander Poltorak
Journal:  J Immunol       Date:  2017-06-14       Impact factor: 5.422

Review 7.  NF-κB in immunobiology.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

Review 8.  Ubiquitination and degradation of the inhibitors of NF-kappaB.

Authors:  Naama Kanarek; Nir London; Ora Schueler-Furman; Yinon Ben-Neriah
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 9.  The regulatory logic of the NF-kappaB signaling system.

Authors:  Ellen O'Dea; Alexander Hoffmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

Review 10.  Ubiquitin in NF-kappaB signaling.

Authors:  Yu-Hsin Chiu; Meng Zhao; Zhijian J Chen
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.